Francisco Ana Paula, Lethbridge Grace, Patterson Beth, Goldman Bergmann Carolina, Van Ameringen Michael
Laboratório de Cronobiologia e Sono, Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul (UFRGS), Rua Ramiro Barcelos, 2350, Av. Protásio Alves, 211 - Santa Cecília, Porto Alegre, RS, 90035-903, Brazil; Programa de Pós-Graduação em Psiquiatria e Ciências do Comportamento, Faculdade de Medicina, UFRGS, Farroupilha, Porto Alegre, RS, 90010-150, Brazil.
MacAnxiety Research Centre, McMaster University, L02-1057 Main St W, Hamilton, ON, L8S 1B7, Canada.
J Psychiatr Res. 2023 Jan;157:239-256. doi: 10.1016/j.jpsychires.2022.11.029. Epub 2022 Nov 25.
Treatments for Adult ADHD include stimulants, two non-stimulant medications, as well as cognitive-behavioral therapy (CBT). These pharmacological agents are often associated with side effects, contributing to poor treatment adherence. Patients with ADHD have regularly stated that cannabis has helped improve their ADHD symptoms; however, scientific literature describing the effects of cannabis on symptoms of ADHD is scarce.
We systematically searched MEDLINE, EMBASE, EMCARE, PsycINFO, Web of Science, Cochrane Library, and Clinicaltrials.gov. The searches included all publications in English up to June 27, 2022. We included both experimental and observational studies that assessed the effect of cannabis on ADHD symptomatology and neuropsychiatric outcomes. To synthesize our current understanding of the potential effects of cannabis use on ADHD symptoms and pathophysiology, and the effects of ADHD on cannabis use, data was extracted from each study regarding the characteristics of its population, methods used to assess both cannabis consumption and ADHD symptoms, and key findings.
Our scoping review included a total of 39 studies. Only one study employed a randomized and placebo-controlled design to directly measure the effect of cannabis on ADHD, and no significant effect was observed for the study's primary outcome, the QbTest (Est = -0.17, 95% CI -0.40 to 0.07, p = 0.16). Most of the literature consists of cross-sectional studies that evaluate the association between ADHD severity and cannabis use. 15 studies addressed the neuropsychiatric effects of cannabis on ADHD by employing either a battery of neuropsychiatric tests or neuroimaging. The concentration and amount of THC and CBD used were not well measured in most of the studies. Although some studies indicated that cannabis improved ADHD symptoms, most studies indicated it worsened or had no effect on ADHD symptoms.
Given the current evidence, cannabis is not recommended for people with ADHD. Limitations of the literature include the absence of objective measurements for cannabis exposure and ADHD symptoms, heterogenous definitions, oversampling, and small sample sizes.
成人注意力缺陷多动障碍(ADHD)的治疗方法包括兴奋剂、两种非兴奋剂药物以及认知行为疗法(CBT)。这些药物通常会产生副作用,导致治疗依从性差。ADHD患者经常表示大麻有助于改善他们的ADHD症状;然而,描述大麻对ADHD症状影响的科学文献却很稀少。
我们系统检索了MEDLINE、EMBASE、EMCARE、PsycINFO、科学网、考克兰图书馆和Clinicaltrials.gov。检索范围包括截至2022年6月27日的所有英文出版物。我们纳入了评估大麻对ADHD症状学和神经精神结局影响的实验性和观察性研究。为了综合我们目前对使用大麻对ADHD症状和病理生理学的潜在影响以及ADHD对大麻使用的影响的理解,从每项研究中提取了有关其人群特征、用于评估大麻消费和ADHD症状的方法以及主要发现的数据。
我们的范围综述共纳入了39项研究。只有一项研究采用了随机和安慰剂对照设计来直接测量大麻对ADHD的影响,该研究的主要结局QbTest未观察到显著影响(估计值=-0.17,95%置信区间-0.40至0.07,p=0.16)。大多数文献由评估ADHD严重程度与大麻使用之间关联的横断面研究组成。15项研究通过使用一系列神经精神测试或神经影像学来探讨大麻对ADHD的神经精神影响。大多数研究中THC和CBD的使用浓度和量未得到很好的测量。尽管一些研究表明大麻改善了ADHD症状,但大多数研究表明它会使ADHD症状恶化或没有影响。
鉴于目前的证据,不建议ADHD患者使用大麻。文献的局限性包括缺乏对大麻暴露和ADHD症状的客观测量、定义异质性、过度抽样以及样本量小。